SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $549,390 | -27.4% | 3,986 | -31.8% | 0.20% | -33.4% |
| Q4 2022 | $757,136 | +17.2% | 5,843 | 0.0% | 0.31% | +19.8% |
| Q3 2022 | $646,000 | +82.5% | 5,843 | +23.6% | 0.26% | +89.0% |
| Q2 2022 | $354,000 | -5.3% | 4,728 | -1.2% | 0.14% | +3.0% |
| Q1 2022 | $374,000 | -17.4% | 4,785 | -4.8% | 0.13% | -14.8% |
| Q4 2021 | $453,000 | +110.7% | 5,028 | +115.9% | 0.16% | +96.2% |
| Q3 2021 | $215,000 | -7.7% | 2,329 | -25.5% | 0.08% | -9.2% |
| Q1 2021 | $233,000 | -73.7% | 3,125 | -39.8% | 0.09% | -74.1% |
| Q4 2020 | $885,000 | +22.2% | 5,192 | +0.7% | 0.34% | +8.0% |
| Q3 2020 | $724,000 | -15.5% | 5,155 | -3.6% | 0.31% | -22.6% |
| Q2 2020 | $857,000 | +13.4% | 5,346 | -30.9% | 0.40% | -0.5% |
| Q1 2020 | $756,000 | -16.8% | 7,733 | +9.7% | 0.40% | -0.2% |
| Q4 2019 | $909,000 | +99.8% | 7,048 | +16.7% | 0.40% | +47.3% |
| Q3 2019 | $455,000 | -50.6% | 6,042 | -0.3% | 0.28% | -49.0% |
| Q2 2019 | $921,000 | +24.8% | 6,062 | -2.1% | 0.54% | +23.1% |
| Q1 2019 | $738,000 | -34.5% | 6,192 | -40.0% | 0.44% | -48.8% |
| Q4 2018 | $1,127,000 | – | 10,323 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |